Brett W Cox

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery
    Brett W Cox
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 83:e661-7. 2012
  2. doi International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery
    Brett W Cox
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 83:e597-605. 2012
  3. doi Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients
    Ilya Laufer
    Departments of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Neurosurg Spine 18:207-14. 2013
  4. doi The NOMS framework: approach to the treatment of spinal metastatic tumors
    Ilya Laufer
    Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Oncologist 18:744-51. 2013
  5. doi Intraoperative 32P high-dose rate brachytherapy of the dura for recurrent primary and metastatic intracranial and spinal tumors
    Michael R Folkert
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Neurosurgery 71:1003-10; discussion 1010-1. 2012
  6. doi Preliminary results of high-dose single-fraction radiotherapy for the management of chordomas of the spine and sacrum
    Yoshiya Yamada
    Departments of Radiation Oncology, Neurosurgery, Medical Physics, and Orthopedics, Memorial Sloan Kettering Cancer Center, New York, New York Department of Neurologic Surgery, Weill Cornell Medical College, New York, New York Departments of Medicine, Pediatrics, and Orthopedics, Mount Sinai School of Medicine, New York, New York
    Neurosurgery 73:673-80; discussion 680. 2013
  7. doi A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer
    Marisa A Kollmeier
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 11:271-6. 2012

Collaborators

Detail Information

Publications7

  1. pmc Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery
    Brett W Cox
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 83:e661-7. 2012
    ..To report the esophageal toxicity from single-fraction paraspinal stereotactic radiosurgery (SRS) and identify dosimetric and clinical risk factors for toxicity...
  2. doi International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery
    Brett W Cox
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 83:e597-605. 2012
    ..However, target volume definition varies considerably and no consensus target volume guidelines exist. This study proposes consensus target volume definitions using common scenarios in metastatic spine radiosurgery...
  3. doi Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients
    Ilya Laufer
    Departments of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Neurosurg Spine 18:207-14. 2013
    ..The authors examine the outcomes of postoperative image-guided intensity-modulated radiation therapy delivered as single-fraction or hypofractionated stereotactic radiosurgery (SRS) for achieving long-term local tumor control...
  4. doi The NOMS framework: approach to the treatment of spinal metastatic tumors
    Ilya Laufer
    Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Oncologist 18:744-51. 2013
    ....
  5. doi Intraoperative 32P high-dose rate brachytherapy of the dura for recurrent primary and metastatic intracranial and spinal tumors
    Michael R Folkert
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Neurosurgery 71:1003-10; discussion 1010-1. 2012
    ..Treatment of spinal and intracranial tumors with dural involvement is complicated by radiation tolerance of sensitive structures, especially in the setting of previous treatment...
  6. doi Preliminary results of high-dose single-fraction radiotherapy for the management of chordomas of the spine and sacrum
    Yoshiya Yamada
    Departments of Radiation Oncology, Neurosurgery, Medical Physics, and Orthopedics, Memorial Sloan Kettering Cancer Center, New York, New York Department of Neurologic Surgery, Weill Cornell Medical College, New York, New York Departments of Medicine, Pediatrics, and Orthopedics, Mount Sinai School of Medicine, New York, New York
    Neurosurgery 73:673-80; discussion 680. 2013
    ..Furthermore, these tumors have shown resistance to fractionated photon radiation at conventional doses and numerous chemotherapies...
  7. doi A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer
    Marisa A Kollmeier
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 11:271-6. 2012
    ..To compare biochemical outcomes and morbidity associated with iodine-125 ((125)I) and palladium-103 ((103)Pd) brachytherapy as part of combined modality therapy for clinically localized prostate cancer...